Supplemental Newborn Screening by MS/MS-Based Second-Tier Testing
Dr. Matern discusses the use of second-tier testing to reduce the number of false-positive results in newborn screening. This is accomplished using mass spectrometry technology. Also discussed: the unique partnership between Mayo Clinic and the Minnesota Department of Health is credited with reducing the number of false-positive test results, the cost of unnecessary follow-up testing, and parental anxiety for Minnesota parents.
- Dr. Dietrich Matern, from the Division of Laboratory Genetics at Mayo Clinic
Forward to a Colleague
If you have questions, email .